Simon Baker
Stock Analyst at Redburn Atlantic
(0.90)
# 3,786
Out of 4,905 analysts
8
Total ratings
25%
Success rate
-3.13%
Average return
Main Sectors:
Stocks Rated by Simon Baker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics | Upgrades: Buy | $13 | $2.41 | +439.42% | 1 | Nov 15, 2024 | |
| BNTX BioNTech SE | Upgrades: Buy | $165 → $170 | $110.02 | +54.52% | 3 | May 17, 2023 | |
| QGEN Qiagen | Initiates: Buy | n/a | $48.36 | - | 1 | Oct 14, 2021 | |
| ABT Abbott Laboratories | Initiates: Neutral | n/a | $123.67 | - | 1 | Oct 14, 2021 | |
| HOLX Hologic | Initiates: Neutral | n/a | $63.99 | - | 1 | Oct 14, 2021 | |
| FOXA Fox Corporation | Upgrades: Hold | $29 → $24 | $56.25 | -57.33% | 1 | Apr 8, 2020 |
Autolus Therapeutics
Nov 15, 2024
Upgrades: Buy
Price Target: $13
Current: $2.41
Upside: +439.42%
BioNTech SE
May 17, 2023
Upgrades: Buy
Price Target: $165 → $170
Current: $110.02
Upside: +54.52%
Qiagen
Oct 14, 2021
Initiates: Buy
Price Target: n/a
Current: $48.36
Upside: -
Abbott Laboratories
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $123.67
Upside: -
Hologic
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $63.99
Upside: -
Fox Corporation
Apr 8, 2020
Upgrades: Hold
Price Target: $29 → $24
Current: $56.25
Upside: -57.33%